News
Search results
Showing matches with:
Tough spring forecast for allergy sufferers
13 03 2025
UAB researcher Jordina Belmonte, head of the Aerobiological Network of Catalonia (XAC) of ICTA-UAB and BABVE, together with Gaspar Dalmau, physician specialising in allergology and president of the Catalan Society of Allergology and Clinical Immunology (SCAIC), presented the forecast of allergenic pollen levels for this spring and the effects they will have on allergy sufferers.
The UAB disables its account on the social network X
26 02 2025
The presence of the UAB in any of the social networks or communication channels of which it makes use does not in any way presuppose sharing the editorial line or other information contained in these networks or channels.
Two cancer research projects of the UAB receive funding from the AECC
26 02 2025
UAB researchers Maria Lluch and Clàudia Faúndez will receive funding from the scientific foundation Associació Espanyola Contra el Càncer (AECC) to develop two projects on glioblastoma and endometrial cancer treatments.
Project to identify new therapies for Alzheimer's disease receives funding from the Alzheimer's Association
12 11 2024
The Alzheimer’s Association will fund UAB projects studying the molecular alterations of inhibitory neurons which take place in patients with Alzheimer's.
Nanoparticles designed to trap and neutralise large amounts of SARS-CoV2
12 11 2024
Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV-2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of COVID-19. Moreover, the nanoparticles could be redesigned to target other pathogens.
UAB researchers cure liver disease MASH by a one-time gene therapy
12 11 2024
UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than 40 million people. The results were obtained with a single intramuscular administration of the therapeutic viral vectors. The research has also determined that most obese, type 2 diabetic and MASH patients could benefit from the therapy. The results will be the basis for a future clinical trial by the biopharmaceutical company Kriya
WHO Laboratory Biosecurity Guidance document
26 06 2024
WHO publishes revised "Laboratory Biosecurity Guidance".
Summer is coming! Don't forget best practices!
25 06 2024
As the weather gets warmer, shorts and sandals become popular choices for outdoor activities. However, when working in a laboratory, it's crucial to wear appropriate attire to minimize the risk of injuries and exposure in the event of an accident.
New edition of the course "Strategies in Biosafety and Biocontainment"
13 06 2024
The registration period for the Postgraduate Course "Strategies in Biosafety and Biocontainment" (13th edition). This course, organized by the Faculties of Biosciences and Veterinary Medicine, has the collaboration of IBC-UAB, IRTA-CReSA and CRAG and is preferably aimed at technicians, lab managers, graduates and professionals in the biomedical, biotechnology, veterinary and agri-food sectors.
15 innovative UAB projects, recognized by the Indústries del Coneixement Program
15 04 2024
15 UAB researcher-driven projects have received funding from the Indústria del Coneixement grant from the Departament de Recerca i Universitats of the Generalitat de Catalunya to improve their value and transfer.